[go: up one dir, main page]

MX2018000333A - Producto de la proteina adhesiva de mejillon y las aplicaciones de este en la supresion de inflamaciones de la piel. - Google Patents

Producto de la proteina adhesiva de mejillon y las aplicaciones de este en la supresion de inflamaciones de la piel.

Info

Publication number
MX2018000333A
MX2018000333A MX2018000333A MX2018000333A MX2018000333A MX 2018000333 A MX2018000333 A MX 2018000333A MX 2018000333 A MX2018000333 A MX 2018000333A MX 2018000333 A MX2018000333 A MX 2018000333A MX 2018000333 A MX2018000333 A MX 2018000333A
Authority
MX
Mexico
Prior art keywords
applications
skin
adhesive protein
mussel adhesive
suppression
Prior art date
Application number
MX2018000333A
Other languages
English (en)
Inventor
Gao Min
Bengt Samuelsson Ingemar
Original Assignee
Bengt I Samuelsson Institute Of Life Science Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bengt I Samuelsson Institute Of Life Science Res filed Critical Bengt I Samuelsson Institute Of Life Science Res
Publication of MX2018000333A publication Critical patent/MX2018000333A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se describen las aplicaciones de una proteína adhesiva de mejillón o preparaciones de esta para suprimir inflamaciones de la piel. Específicamente, se describen aplicaciones de una proteína adhesiva de mejillón, preparaciones de esta y aplicaciones de esta en dermatitis, eccema, úlcera de piel, tecnologías relacionadas a las quemaduras (que comprenden injerto de piel), sabañones, incisiones quirúrgicas, herpes, abrasiones, cicatrices, psoriasis, eritema multiforme, daño de la piel luego de radioterapia, cáncer de piel, foliculitis, urticaria y erupción causada por fármacos, y aplicaciones en quemaduras causadas por el sol, erupción lumínica polimorfa, alopecia patológica (que comprende trasplante capilar), acné vulgar, rosácea (es decir, acné rosácea) y similares, y aplicaciones en el tratamiento de otitis externa.
MX2018000333A 2015-07-20 2015-07-20 Producto de la proteina adhesiva de mejillon y las aplicaciones de este en la supresion de inflamaciones de la piel. MX2018000333A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2015/084492 WO2017011982A1 (zh) 2015-07-20 2015-07-20 贻贝粘蛋白产品及其抑制皮肤炎症的应用

Publications (1)

Publication Number Publication Date
MX2018000333A true MX2018000333A (es) 2018-05-22

Family

ID=57833543

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018000333A MX2018000333A (es) 2015-07-20 2015-07-20 Producto de la proteina adhesiva de mejillon y las aplicaciones de este en la supresion de inflamaciones de la piel.

Country Status (12)

Country Link
US (1) US10568938B2 (es)
EP (1) EP3326639B1 (es)
JP (1) JP6778219B2 (es)
KR (1) KR102468519B1 (es)
CN (2) CN108348577B (es)
AU (1) AU2015402832B2 (es)
BR (1) BR112018000953A2 (es)
CA (1) CA2992109C (es)
DK (1) DK3326639T3 (es)
MX (1) MX2018000333A (es)
SG (1) SG11201800440SA (es)
WO (1) WO2017011982A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017011986A1 (zh) 2015-07-20 2017-01-26 赵兵 一种空气过滤装置
KR102468524B1 (ko) 2015-07-20 2022-11-18 장인 벵트 아이. 사무엘손 인스티튜트 오브 라이프 사이언스 컴퍼니 리미티드 멜라닌과 관련된 질환의 치료 및 예방에서의 홍합 접착 단백질 제품의 용도
WO2017028025A1 (zh) 2015-08-14 2017-02-23 江阴市本特塞缪森生命科学研究院有限公司 贻贝粘蛋白产品及其抑制粘膜炎症的应用
CN113491696A (zh) * 2017-07-05 2021-10-12 江阴优培尔康药业有限公司 包含孟鲁司特与贻贝粘附蛋白的组合的局部制剂
MA52988A (fr) * 2017-07-05 2021-05-05 Jiangyin Usun Pharmaceutical Co Ltd Utilisation anti-inflammatoire du peptide
WO2019011286A1 (en) * 2017-07-14 2019-01-17 Jiangyin Usun Pharmaceutical Co., Ltd. ANTIVIRAL USE OF MEMBRANE ADHESIVE PROTEINS
WO2019228307A1 (en) * 2018-05-28 2019-12-05 Jiangyin Usun Pharmaceutical Co., Ltd. New pharmaceutical use
PT3678705T (pt) * 2018-09-14 2023-07-19 Enlitisa Shanghai Pharmaceutical Co Ltd Conjugado de montelucaste e péptidos
CN120919118A (zh) * 2019-01-10 2025-11-11 艾缇亚(上海)制药有限公司 含有白三烯受体拮抗剂的新型配制品
CN109925501A (zh) * 2019-04-26 2019-06-25 贝亲母婴用品（上海）有限公司 一种用于改善皮肤屏障的组合物
CN110522667B (zh) * 2019-08-08 2022-06-10 王斌 一种由纤连蛋白附着的面膜及其生产工艺
CN110384651B (zh) * 2019-09-05 2022-06-10 广州市华侬化妆品股份有限公司 修复过敏性皮肤及治疗湿疹的精华液
AU2020344762A1 (en) * 2019-09-14 2022-04-14 Jiangyin Usun Pharmaceutical Co., Ltd. New peptides
KR20220119051A (ko) * 2019-12-02 2022-08-26 엔리티사 (상하이) 파마슈티컬 컴퍼니 리미티드 신규한 다기능성 올리고펩타이드
JP2023503380A (ja) * 2019-12-02 2023-01-27 エンリティザ（シャンハイ）ファーマシューティカル カンパニー リミテッド ペプチド及び炎症の治療におけるそれらの使用
CN112315840A (zh) * 2020-11-20 2021-02-05 广州植境生物科技有限公司 一种贻贝粘蛋白头皮修护组合物、修护液及其制备方法
KR102596264B1 (ko) 2020-11-30 2023-11-01 주식회사 바이오빛 기능성 펩티드가 결합된 생체적합 폴리펩티드를 포함하는 염증 질환의 억제용 조성물
CN113975228B (zh) * 2021-10-18 2023-06-23 江西省肿瘤医院(江西省第二人民医院、江西省癌症中心) 一种妇科抗菌凝胶及其应用
CN113989138B (zh) * 2021-10-21 2024-07-16 武汉博视电子有限公司 一种脸部肌肤图像炎症提取并形成红区光谱的方法
CN115852521A (zh) * 2022-10-25 2023-03-28 邵阳深镁科技时尚有限公司 一种环保假发及其制备方法
CN117398511B (zh) * 2023-10-18 2024-04-12 珠海市雅莎医疗器械有限公司 激光、光子术后修复的贻贝粘蛋白修护敷料及其制备方法
CN117617500A (zh) * 2023-12-27 2024-03-01 南京玉鹤鸣医学营养科技股份有限公司 一种适用于术后恢复的功能型配方粉及其制备方法和用法
CN117860903B (zh) * 2024-01-09 2024-08-23 贝壳派创新科技（深圳）有限公司 一种基于贻贝粘蛋白的止痒组合物及其制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
RU2043109C1 (ru) * 1992-03-17 1995-09-10 Маина Александровна Бичурина Способ ингибиции вируса гриппа серотипов а и в
CN1112831A (zh) * 1994-05-30 1995-12-06 乌力吉 含蜗牛提取液的长效多功能营养护肤水及其制法
AUPN531195A0 (en) * 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity
NZ314867A (en) 1997-05-21 1999-04-29 Mcfarlane Lab New Zealand Ltd Glucosamine and mussel extract compositions for use as anti-inflammatories
JP2002517300A (ja) 1998-06-10 2002-06-18 ジョージア テック リサーチ コーポレイション 微小針デバイスおよび製造方法ならびにそれらの使用
US20020018787A1 (en) 1999-05-21 2002-02-14 Roger V. Kendall Methods and compositions for modulating immune response and for the treatment of inflammatory disease
DE60038320D1 (de) 1999-07-21 2008-04-24 Bomac Research Ltd Mittel zur bekämpfung von entzündungen und/oder degenerativen erkrankungen
AU6907600A (en) 1999-08-16 2001-03-13 Playtex Products, Inc. Sunscreen lotion or spray composition
US6770302B2 (en) * 2001-03-30 2004-08-03 Department Of Biotechnology Indian green mussel (Perna viridis) as a source of anti-HIV activity
US7074433B2 (en) * 2001-03-30 2006-07-11 Council Of Scientific And Industrial Research Process for the cure and control of Diabetes mellitus using natural products from Perna viridis
US6905710B2 (en) * 2001-08-31 2005-06-14 Council Of Scientific And Industrial Research Pharmaceutical composition useful for inhibition of osteoclast formation and a process for the extraction of mussel hudrolysate from indian green mussel
US20060275370A1 (en) 2002-07-25 2006-12-07 Yih-Lin Chung Method and compositions for treatment of epithelial damage
US7704518B2 (en) * 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
EP1722630A4 (en) 2004-01-20 2009-05-27 Richard F Harty COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES
NZ563125A (en) * 2005-06-03 2009-11-27 Mcfarlane Marketing Aust Pty L Lipid extract of mussels and method for preparation thereof
KR100852864B1 (ko) * 2007-04-13 2008-08-18 보령메디앙스 주식회사 초록입 홍합(Ｐｅｒｎａ Ｃａｎａｌｉｃｕｌｕｓ.)추출물을 함유하는 화장료 조성물
CN101348520B (zh) 2007-12-14 2011-10-12 顾铭 一种使用混合吸附色谱分离纯化贻贝粘蛋白的方法
CN101348518B (zh) 2007-12-14 2011-09-28 顾铭 一种使用羧甲基离子交换色谱纯化贻贝粘蛋白的方法
CN101585874B (zh) 2009-06-30 2012-08-22 江阴贝瑞森生化技术有限公司 一种使用盐析和透析分离纯化贻贝粘蛋白的方法
CN101953813A (zh) * 2009-07-16 2011-01-26 陕西步长制药有限公司 黄藤素泡腾片及其制法和检测方法
US8673986B2 (en) 2009-08-25 2014-03-18 Postech Academy-Industry Foundation Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof
KR101147847B1 (ko) 2010-06-02 2012-05-24 건국대학교 산학협력단 패류 유래 기능성 펩티드의 분리 정제 방법 및 기능성 펩티드의 용도
CN101991840B (zh) 2010-09-26 2012-09-05 浙江海洋学院 抗前列腺癌贻贝酶解提取物的制备方法及应用
KR101384746B1 (ko) 2011-08-24 2014-04-14 포항공과대학교 산학협력단 홍합 접착 단백질을 이용한 다양한 기능성 생체분자의 표면 고정화
CN102302417B (zh) 2011-09-13 2012-12-26 佛山市安安美容保健品有限公司 一种含有海洋生物活性物质的全效防晒乳液
WO2013143077A1 (zh) 2012-03-28 2013-10-03 江阴贝瑞森生化技术有限公司 使用多模式色谱纯化贻贝粘蛋白的方法
WO2014186937A1 (zh) * 2013-05-20 2014-11-27 Gao Min 贻贝粘蛋白凝胶的制备方法、贻贝粘蛋白凝胶及其应用
CN103520766A (zh) * 2013-09-25 2014-01-22 高敏 贻贝粘蛋白液体产品、其制备方法及其应用
CN104323927A (zh) 2014-11-06 2015-02-04 济南星河康泰贸易有限公司 贻贝粘蛋白在制备皮肤美容化妆品上的应用
CN104645313A (zh) * 2015-01-28 2015-05-27 南京航空航天大学 一种修复止痒贻贝粘蛋白凝胶剂及其制备方法
CN104645320A (zh) 2015-01-28 2015-05-27 南京航空航天大学 一种创面修复用贻贝粘蛋白凝胶剂及其制备方法和应用
CN104857552B (zh) 2015-05-18 2018-08-10 赵明 一种止血贴及其制备方法
KR102468524B1 (ko) 2015-07-20 2022-11-18 장인 벵트 아이. 사무엘손 인스티튜트 오브 라이프 사이언스 컴퍼니 리미티드 멜라닌과 관련된 질환의 치료 및 예방에서의 홍합 접착 단백질 제품의 용도
WO2017028025A1 (zh) 2015-08-14 2017-02-23 江阴市本特塞缪森生命科学研究院有限公司 贻贝粘蛋白产品及其抑制粘膜炎症的应用

Also Published As

Publication number Publication date
EP3326639A4 (en) 2019-03-27
EP3326639B1 (en) 2023-11-01
CA2992109A1 (en) 2017-01-26
AU2015402832B2 (en) 2022-06-02
CN114558110B (zh) 2024-06-25
KR102468519B1 (ko) 2022-11-21
SG11201800440SA (en) 2018-02-27
CN108348577B (zh) 2022-03-01
US10568938B2 (en) 2020-02-25
BR112018000953A2 (pt) 2018-09-11
JP6778219B2 (ja) 2020-10-28
CN114558110A (zh) 2022-05-31
DK3326639T3 (en) 2024-01-08
CN108348577A (zh) 2018-07-31
AU2015402832A1 (en) 2018-01-25
WO2017011982A1 (zh) 2017-01-26
JP2018525348A (ja) 2018-09-06
KR20180029228A (ko) 2018-03-20
US20180228873A1 (en) 2018-08-16
EP3326639A1 (en) 2018-05-30
HK1255897A1 (en) 2019-08-30
CA2992109C (en) 2022-10-11

Similar Documents

Publication Publication Date Title
MX2018000333A (es) Producto de la proteina adhesiva de mejillon y las aplicaciones de este en la supresion de inflamaciones de la piel.
PH12018502429A1 (en) Antibody molecules for cancer treatment
WO2018112365A3 (en) Methods of treating colorectal cancer and melanoma using parabacteroides goldsteinii
EP4272834A3 (en) Therapeutic use of mitochondria and combined mitochondrial agents
EP3630089A4 (en) PROCEDURE FOR CANCER THERAPY
EA201991790A1 (ru) Терапевтические препараты апремиласта для местного применения
EP4292650A3 (en) Heterocyclic compounds as immunomodulators
AU2018347307A1 (en) Heterocyclic compounds and uses thereof
ZA201902275B (en) Topical dressing composition for the treatment of damaged skin tissue
WO2014012075A3 (en) Treating hair loss and delaying aging of skin
AU2018253575A1 (en) Natural killer cells from placenta
AU2019383310B2 (en) Aryl-aniline and heteroaryl-aniline compounds for treatment of skin cancers
MX2016009663A (es) Derivados de icariina.
BR112018000955A2 (pt) aplicações de produto de proteína adesiva de mexilhão no tratamento e prevenção de doenças relacionadas à melanina
WO2017027359A8 (en) Pyridines and their use in the treatment of cancer
EP4512816A3 (en) Tlr7 agonists
EP4330241A4 (en) MOLEPHANTIN DERIVATIVES USEFUL IN THE TREATMENT OF CANCER
EP3871040A4 (en) COSMETIC HOLOGRAPHIC BODY-WEARABLE EYE DEVICES AND METHOD FOR THEIR MANUFACTURE
GB202317288D0 (en) Pyrrolopyridone derivatives useful in the treatment of cancer
EP3720411A4 (en) TOPICAL Ointment FORMULATIONS BY PDE-4 INHIBITORS AND THEIR USE FOR TREATMENT OF SKIN DISEASES
EP3432903A4 (en) HERBAL NANO FORMULATIONS FOR TREATING PSORIASIS AND OTHER SKIN DISEASES
MX2017016226A (es) Composiciones farmaceuticas que comprenden derivados de polialquilenglicol.
EP3737373A4 (en) METHODS AND POLYTHERAPY FOR TREATING CANCER
AU2017268453A8 (en) Synthetic malaria immunogens, combinations thereof, and their use to prevent and treat malaria infections
EP3592357A4 (en) METHOD OF TREATMENT OF CANCER